InvestorsHub Logo
Followers 2
Posts 786
Boards Moderated 0
Alias Born 06/14/2005

Re: FDApproved post# 44001

Thursday, 11/10/2022 10:23:18 PM

Thursday, November 10, 2022 10:23:18 PM

Post# of 44784
The last 2 pages of the 10Q are very concerning. The outlook for the short and near term don't look good. Revenues for the next 12 months will be less than costs. And, saving the worst for last, they may initiate a reverse stock split in order to meet Nasdaq compliance.